Literature DB >> 3658845

Propranolol pharmacokinetics during the menstrual cycle.

I Abdu-Aguye1, D Dunlop, P Patel, P Turner.   

Abstract

The pharmacokinetics of propranolol during menstruation and in the mid menstrual cycle have been studied in nine young women taking a single 80 mg tablet on each occasion. There were wide between-individual differences in the serum concentration at any given time (4-5 fold at peak concentrations) but the serum concentration time curves within individuals showed only mild variations. The differences between the average pharmacokinetic parameter estimates for the group did not differ significantly between the two periods of study.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3658845      PMCID: PMC2418948          DOI: 10.1136/pgmj.62.734.1093

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  11 in total

1.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

Review 2.  Beta-adrenoceptor blockade and migraine.

Authors:  K Weerasuriya; L Patel; P Turner
Journal:  Cephalalgia       Date:  1982-03       Impact factor: 6.292

3.  Serum concentrations of propranolol and migraine prophylaxis.

Authors:  F M Gengo; S C Fagan; W R Kinkel; W B McHugh
Journal:  Arch Neurol       Date:  1984-12

4.  Problems and pitfalls in estimating average pharmacokinetic parameters.

Authors:  E Martin; W Moll; P Schmid; L Dettli
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Influence of cimetidine on pharmacokinetics of propranolol.

Authors:  A M Heagerty; M A Donovan; C M Castleden; J F Pohl; L Patel; A Hedges
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-13

6.  The effect of age on plasma levels of propranolol and practolol in man.

Authors:  C M Castleden; C M Kaye; R L Parsons
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

7.  Biologic determinants of propranolol disposition: results from 1308 patients in the Beta-Blocker Heart Attack Trial.

Authors:  T Walle; R P Byington; C D Furberg; K M McIntyre; P S Vokonas
Journal:  Clin Pharmacol Ther       Date:  1985-11       Impact factor: 6.875

8.  Antipyrine metabolism during the menstrual cycle.

Authors:  E F Riester; E J Pantuck; C B Pantuck; G T Passananti; E S Vesell; A H Conney
Journal:  Clin Pharmacol Ther       Date:  1980-09       Impact factor: 6.875

9.  Propranolol concentrations in plasma after insertion into the vagina.

Authors:  L G Patel; S J Warrington; R M Pearson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-29

10.  Central effects of single oral doses of propranolol in man.

Authors:  S A Salem; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

View more
  1 in total

Review 1.  Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs.

Authors:  A D Kashuba; A N Nafziger
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.